Polaris Market Research presents its latest market research report, titled AI in Pathology Market Report, 2025–2034. It is a comprehensive market research report analyzing the fast-evolving AI in Pathology market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The study is a combination of qualitative and quantitative analysis, giving insights about the size of the market, segments, regional performance, and industry developments. By going through the report, stakeholders can get an in-depth overview of the AI in Pathology market and its outlook during the forecast period.
AI in Pathology Market Key Takeaways
- The AI in pathology market was valued at USD 27.69 billion in 2024 and USD 31.81 billion in 2025.
- The market is estimated to reach USD 113.02 billion by 2034.
- The market is projected to witness a CAGR of 15.10% from 2025 to 2034.
- The End-to-End Solutions segment held the largest share by offering in 2024.
- The GANs (Generative Adversarial Networks) segment is likely to grow at the fastest CAGR by neural network.
- The North America region held the largest share of the market in 2024.
- Asia Pacific is expected to register the highest growth rate over the forecast period.
What is AI in Pathology Market?
AI in pathology refers to the use of machine learning and deep learning software to analyze medical images and pathology slides, helping automate disease detection, classification, and diagnostic reporting. Spanning offerings, neural-network types, and use cases from drug discovery to clinical diagnosis, it enhances diagnostic accuracy, reduces manual workload, and speeds turnaround for hospitals, laboratories, and biopharmaceutical companies.
Market Dynamics
The report examines the key market dynamics influencing the growth and development of the AI in Pathology market. It analyzes the market drivers, market opportunities, market trends, and restraints that might impact the growth of the market.
Key Market Driver: Rising Prevalence of Cancer and Chronic Diseases
The World Health Organization projects new cancer cases will exceed 35 million by 2050, a 77% increase from roughly 20 million cases in 2022. This rising disease burden is driving demand for AI-based pathology solutions that help manage growing sample volumes while improving diagnostic accuracy and turnaround time.
Read More @ https://www.polarismarketresearch.com/industry-analysis/ai-in-pathology-market
Market Opportunity: Increasing R&D Investment in Biomarker Discovery
Pharmaceutical and biotechnology firms are channeling significant capital into AI-driven pathology platforms for biomarker discovery. Proscia's USD 50 million funding round in March 2025 for its Concentriq platform illustrates strong investor confidence in AI-enabled diagnostics that can accelerate drug-development timelines through molecular target validation.
Emerging Market Trend: Emergence of Explainable AI (XAI)
The growing integration of transparent, interpretable AI outputs is easing regulatory clearance and clinical adoption of AI pathology tools, helping pathologists better trust and act on AI-generated diagnostic insights as the technology becomes more embedded in routine workflows.
Market Challenge: High Implementation Costs
Deploying AI platforms and digital pathology infrastructure requires substantial upfront investment in hardware, software, and staff training, posing a significant barrier for smaller laboratories and academic institutions operating with constrained budgets.
Who Are the Key Market Players?
The report presents a detailed competitive analysis of the AI in Pathology industry. Player positioning and their strategy, such as new product/service launches, partnerships, mergers and acquisitions, geographic expansion, capacity expansion, technological developments, etc., have been analyzed. The report also examines the competitive structure of the industry and how organizations are responding to changing consumer demands.
A few of the key players in the market include:
- Aiforia Technologies Plc
- Akoya Biosciences, Inc.
- Deep Bio Inc.
- Hologic, Inc.
- Ibex Medical Analytics Ltd.
- Indica Labs Inc.
- Koninklijke Philips N.V.
Future Outlook
The AI in pathology market is projected to grow and evolve until the forecast year 2034 as disease burden rises, digital pathology infrastructure expands, and industry players respond to changing clinical and regulatory demands. Continued innovation in neural-network architectures, explainable AI, and strategic partnerships between AI vendors and healthcare systems are expected to drive market development and present new opportunities across major segments and geographies. This report provides insights into how the market is expected to evolve, thereby enabling stakeholders to understand opportunities and developments likely to shape the market during the forecast period.
More Trending Latest Reports By Polaris Market Research:
it-asset-disposition-itad-market
dental-service-organization-market
data-center-interconnect-market
